Variable | Primary site | |||||||
---|---|---|---|---|---|---|---|---|
Prostate | Breast | Cervical | Colorectal | Lung | Stomach | Oesophagus | Oral cavity | |
HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | |
Sex | ||||||||
Male | - | 1.00 | - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Female | - | 2.46 (0.61; 9.93) | - | 0.88 (0.74; 1.05) | 0.78 (0.66; 0.91) | 0.86 (0.70; 1.06) | 1.03 (0.77; 1.38) | 1.10 (0.79; 1.55) |
Age-group | ||||||||
<60 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
60+ | 1.49 (1.13; 1.98) | 1.29 (1.10; 1.52) | 1.04 (0.81; 1.32) | 1.27 (1.07; 1.52) | 1.10 (0.95; 1.28) | 0.92 (0.75; 1.11) | 1.11 (0.900; 1.38) | 1.41 (1.06; 1.88) |
Stage disease | ||||||||
I | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
II | 2.22 (0.71; 6.96) | 2.48(1.59; 3.86) | 1.99 (1.26; 3.15) | 1.94 (1.36; 2.78) | 1.59 (0.82; 3.07) | 3.60 (2.09; 6.22) | 4.98 (1.80; 13.82) | 2.10 (1.07; 4.15) |
III | 3.79 (1.20; 11.90) | 8.10 (5.22; 12.59) | 4.91 (3.18; 7.57) | 3.23 (2.26; 4.63) | 2.24 (1.36; 3.68) | 6.73 (3.99; 11.35) | 7.26 (2.63; 20.07) | 3.03 (1.57; 5.86) |
IV | 20.13 (6.44; 62.94) | 18.30 (11.67; 28.71) | 10.84 (6.73; 17.47) | 13.44 (9.39; 19.24) | 4.88 (2.95; 8.06) | 15.93 (9.62; 26.37) | 12.00 (4.29; 33.56) | 6.34 (3.34; 12.02) |